Pfizer: JAK1 inhibitor Xibico has been approved as a new indication for age expansion in China
坠落天使
发表于 2024-3-4 18:35:20
3964
0
0
Pfizer: JAK1 inhibitor Xibico has been approved as a new indication for age extension in China. Pfizer announced that the highly selective JAK1 inhibitor and innovative oral small molecule targeted drug Xibico have been officially approved by the National Medical Products Administration (NMPA) of China for the treatment of moderate to severe atopic dermatitis in adolescents and adults aged 12 and above.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
猜你喜欢
- Pfizer and Shangyao Holdings have reached a strategic cooperation to jointly create a new format of high-quality preventive immunization services
- Pfizer CEO may meet with key executives of radical investor Starboard Value next week
- The first weekly long-acting hemophilia therapy has been approved by the FDA from Pfizer
- Pfizer Beijing R&D Center settles in BioPark, Beijing Medical Innovation Park
- Pfizer will make an appearance at the 7th CIIE and make a commitment to its development for the next five years
- Pfizer's innovative targeted therapy drug Taizena has been approved in China
- Exhibits become commodities in seconds! Prostate cancer new drug approved in China, Pfizer Wang Yu: promoting China's new drug market to synchronize with the global market
- Exploring the CIIE | New products from Sinogen, Roche, and Pfizer become highlights of the CIIE
- Pfizer plans to sell hospital drug division, company responds
- After closing factories and laying off employees, Pfizer is reportedly considering selling its hospital drug division
-
知名做空机构香橼研究（Citron Research）周四（11月21日）在社交媒体平台X上发布消息称，该公司已决定做空“比特币大户”微策略（Microstrategy）这家公司，并认为该公司已经将自己变身成为一家比特币投资基金 ...- caffycat
- 前天 11:18
- 支持
- 反对
- 回复
- 收藏
-
人民网北京11月22日电 （记者栗翘楚、任妍）2024广州车展，在新能源汽车占据“半壁江山”的同时，正加速向智能网联新能源汽车全面过渡，随着“端到端”成为新宠，智能驾驶解决方案成为本届广州车展各大车企竞 ...- 3233340
- 前天 17:06
- 支持
- 反对
- 回复
- 收藏
-
11月21日晚，百度发布2024年第三季度财务报告。财报显示百度季度总营收336亿元，净利润76亿美元，同比上升14%。百度核心营收265亿元，归属百度核心的净利润75.4亿元，同比增长17%。财报显示，11月，文心大模型日 ...- jiliang
- 前天 14:26
- 支持
- 反对
- 回复
- 收藏
-
币圈又迎重大利好？特朗普团队据称考虑设立史上首个白宫加密货币职位。- abcnews
- 3 天前
- 支持
- 反对
- 回复
- 收藏
